![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 9/64 |
(11) | Number of the document | 2635677 |
(13) | Kind of document | T |
(96) | European patent application number | 11781973.0 |
Date of filing the European patent application | 2011-11-03 | |
(97) | Date of publication of the European application | 2013-09-11 |
(45) | Date of publication and mention of the grant of the patent | 2020-01-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/059233 |
Date | 2011-11-03 |
(87) | Number | WO 2012/061654 |
Date | 2012-05-10 |
(30) | Number | Date | Country code |
456298 P | 2010-11-03 | US |
(72) |
MADISON, Edwin, L., US
THANOS, Christopher, US
BLOUSE, Grant, Ellsworth, DK
|
(73) |
Catalyst Biosciences, Inc.,
611 Gateway Blvd., Suite 710, South San Francisco, CA 94080,
US
|
(54) | MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF |
MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF |